Prescription Medications, Brand Names Beginning with ‘T’, Page 15

Page 15 of 328 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

Tadalafil

Tadalafil Tablets are phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia (BPH) (1…

Unichem Pharmaceuticals (USA), Inc.24 November 2022

Tadalafil

Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia (BPH) (1…

Preferred Pharmaceuticals Inc.28 November 2022

Tadalafil

Tadalafil tablet is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia…

NIVAGEN PHARMACEUTICALS, INC.8 December 2022

Tadalafil

Tadalafil tablets USP are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia…

Zydus Pharmaceuticals USA Inc.8 December 2022

Tadalafil

Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia (BPH) (1.2) ED…

Cipla USA Inc.8 December 2022

Page 15 of 328 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.